RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Andrew Koppisch to Escherichia coli Proteins

This is a "connection" page, showing publications Andrew Koppisch has written about Escherichia coli Proteins.
Connection Strength

0.369
  1. Bartee D, Sanders S, Phillips PD, Harrison MJ, Koppisch AT, Freel Meyers CL. Enamide Prodrugs of Acetyl Phosphonate Deoxy-d-xylulose-5-phosphate Synthase Inhibitors as Potent Antibacterial Agents. ACS Infect Dis. 2019 03 08; 5(3):406-417.
    View in: PubMed
    Score: 0.154
  2. Sanders S, Bartee D, Harrison MJ, Phillips PD, Koppisch AT, Freel Meyers CL. Growth medium-dependent antimicrobial activity of early stage MEP pathway inhibitors. PLoS One. 2018; 13(5):e0197638.
    View in: PubMed
    Score: 0.147
  3. Koppisch AT, Khosla C. Structure-based mutagenesis of the malonyl-CoA:acyl carrier protein transacylase from Streptomyces coelicolor. Biochemistry. 2003 Sep 23; 42(37):11057-64.
    View in: PubMed
    Score: 0.053
  4. Kumar P, Koppisch AT, Cane DE, Khosla C. Enhancing the modularity of the modular polyketide synthases: transacylation in modular polyketide synthases catalyzed by malonyl-CoA:ACP transacylase. J Am Chem Soc. 2003 Nov 26; 125(47):14307-12.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support